Study guide

1.1 Public Health Model & the IOM Continuum of Care

IC&RC Prevention Specialist PS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Foundations of Prevention & Public Health

1.1 Public Health Model & the IOM Continuum of Care 1.2 Risk and Protective Factors Framework 1.3 ATOD Fundamentals & Adolescent Brain Development 1.4 Substance Use Progression, SUD Warning Signs, Harm Reduction & Recovery Systems 1.5 Mental, Emotional & Behavioral Health: Warning Signs, Co-Occurring Disorders & Family Impact

2 Chapter 2: Community Assessment & Needs Analysis

2.1 Strategic Prevention Framework (SPF) & Step 1 Assessment 2.2 Quantitative and Qualitative Data Collection Methods 2.3 Community Readiness Model & Assessment

3 Chapter 3: Strategic Planning & Logic Models

3.1 SPF Capacity Building & Strategic Planning Steps 3.2 Problem Statements & Root Cause Analysis 3.3 Constructing Logic Models & Theories of Change

4 Chapter 4: Implementation, Monitoring & Evaluation

4.1 Formulating SMART and SMARTIE Objectives 4.2 Process Evaluation vs. Outcome Evaluation 4.3 Evaluation Designs, Measurement Tools & Data Validity 4.4 Continuous Quality Improvement & Fidelity Monitoring

5 Chapter 5: Evidence-Based Prevention Programs

5.1 The CSAP Six Core Prevention Strategies 5.2 Evidence-Based Curricula across the Lifespan 5.3 Balancing Program Fidelity with Cultural Adaptation

6 Chapter 6: Curriculum Delivery & Facilitation Dynamics

6.1 Adult and Youth Learning Principles in Prevention 6.2 Group Dynamics, Facilitation & Safe Learning Climates 6.3 Trauma-Informed Principles & ACEs in Service Delivery

7 Chapter 7: Developmental Frameworks & Priority Populations

7.1 Search Institute 40 Developmental Assets & Resiliency 7.2 Tailoring Interventions for Specific & Vulnerable Populations

8 Chapter 8: Health Communication Theories & Framing

8.1 Health Behavior Theories in Prevention Messaging 8.2 Social Marketing Principles (4 Ps & Audience Segmentation) 8.3 Strategic Framing, Counter-Marketing & Fear Appeals

9 Chapter 9: Multi-Channel Outreach & Public Speaking

9.1 Media Advocacy & News Media Relations 9.2 Digital Campaigns, Social Media & Plain Language 9.3 Public Speaking, Community Presentations & Data Storytelling 9.4 Person-First Language & Substance Use Stigma Reduction

10 Chapter 10: Coalition Building & Community Mobilization

10.1 Community Coalition Development & Lifecycle Stages 10.2 CADCA 12 Community Sectors & Stakeholder Recruitment 10.3 Coalition Structure, Bylaws & Collaborative MOUs 10.4 Community Mobilization, Grassroots Engagement & Power Sharing

11 Chapter 11: Capacity Building & Sustainability

11.1 Addressing Denial, Resistance & Building Community Will 11.2 Cultural Humility, Diversity & Inclusion in Coalitions 11.3 Resolving Turf Battles & Inter-Agency Conflict 11.4 Comprehensive Sustainability Planning & Funding Diversity 11.5 Integrating Prevention into Physical & Behavioral Health Planning

12 Chapter 12: Environmental Prevention Strategies

12.1 Environmental Strategies & Cohen's Spectrum of Prevention 12.2 Controlling Physical, Social, and Commercial Availability 12.3 Policy Enforcement, Compliance Checks & Pricing Levers

13 Chapter 13: Policy Development, Advocacy & Legal Boundaries

13.1 The Public Health Policy Development Cycle 13.2 Advocacy vs. Lobbying: 501(c)(3) Restrictions & Permissible Actions 13.3 Major Policy Frameworks (Synar, MLSA 21, DFC Act)

14 Chapter 14: Prevention Ethics & Professional Conduct

14.1 The Prevention Code of Ethics (Think Tank 6 Principles) 14.2 Scope of Practice: Prevention vs. Treatment & Counseling 14.3 Dual Relationships, Boundaries & Conflicts of Interest

15 Chapter 15: Legal Mandates, Confidentiality & Participant Safety

15.1 Confidentiality Protocols (FERPA, HIPAA, 42 CFR Part 2) 15.2 Mandatory Child Abuse Reporting & Duty to Protect 15.3 Intellectual Property, Curriculum Integrity & Financial Transparency

16 Chapter 16: Professional Competence, Cultural Humility & Self-Care

16.1 Cultural Humility, Implicit Bias & Health Equity 16.2 Compassion Fatigue, Burnout & Ethical Self-Care 16.3 Prevention Supervision, Reciprocity & Credential Renewal

1.1 Public Health Model & the IOM Continuum of Care

Key Takeaways Explain This Topic AI

The public health model shifts the paradigm from individual pathology to population-level wellness through the epidemiological triad of Host, Agent, and Environment.

The Institute of Medicine (IOM) Continuum of Care classifies behavioral health interventions into four primary stages: Promotion, Prevention, Treatment, and Maintenance.

Prevention interventions occur entirely prior to the onset of a diagnosable disorder and are categorized into Universal, Selective, and Indicated tiers based on population risk profiles.

Universal prevention serves entire unselected populations, Selective prevention targets subgroups with elevated biological or environmental risk, and Indicated prevention addresses individuals with early experimental symptoms or precursors.

Primary prevention leverages epidemiological surveillance data (e.g., NSDUH, YRBS, MTF) to detect community patterns and deploy interventions at the optimal developmental window.

Last updated: September 2026

1.1 Public Health Model & the IOM Continuum of Care

Core Foundation: Contemporary substance use prevention is rooted in the public health model , which prioritizes the health and well-being of entire communities rather than focusing exclusively on treating individuals who have already developed a disorder. By analyzing systemic patterns, addressing root environmental causes, and intervening before clinical pathology takes hold, prevention specialists protect community wellness and reduce the collective burden of behavioral health conditions.

The Public Health Model vs. The Medical Model

To understand modern prevention, credentialed prevention professionals must first distinguish between the traditional medical (clinical) model and the public health model :

The Medical Model: Focuses on the individual patient. It is reactive, identifying symptoms, diagnosing disease entities (such as a severe Substance Use Disorder under DSM-5), and applying medical or psychotherapeutic treatments to restore health or manage chronic illness.

The Public Health Model: Focuses on entire populations or geographic communities. It is proactive and preventative, seeking to alter the conditions, policies, and environments that foster disease, injury, or substance misuse before those issues materialize.

  • Dimension Medical (Clinical) Model Public Health Model
  • Primary Focus Individual patient Entire population or community
  • Timing of Action Post-onset (reactive) Pre-onset (proactive)

Intervention Goal Cure, symptom reduction, rehabilitation Disease prevention, health promotion, systemic change

Key Mechanisms Pharmacotherapy, individual/group psychotherapy Policy change, environmental design, education, norm shifting

Locus of Assessment Clinical diagnostic criteria, biomarker testing Community surveillance, epidemiological rate indicators

Traditional public health conceptualizes disease and health conditions across three levels of prevention:

Primary Prevention: Preventing the initial onset of disease, injury, or substance use among individuals who do not currently have the condition.

Secondary Prevention: Early detection and prompt intervention during the initial or latent stages of a condition to arrest its progression and minimize harm.

Tertiary Prevention: Managing, treating, and rehabilitating established clinical conditions to prevent severe complications, disability, or premature mortality.

In substance use prevention, certified prevention specialists primarily direct their competencies toward primary prevention , stopping initiation and mitigating risk factors before neurobiological dependence or clinical disorders emerge.

The Public Health Epidemiological Triad

Epidemiology—the scientific study of the distribution and determinants of health-related states or events in specified populations—provides the analytical framework for prevention. At the core of epidemiology is the Epidemiological Triad , which posits that disease or health-compromising behavior arises from complex, dynamic interactions among three components: [AGENT]

  • / \
  • / \
  • / \
  • / VECTOR \
  • / \
  • [HOST]---------------[ENVIRONMENT]
  • 1. The Host

The host is the individual person or organism susceptible to the health condition. In substance use prevention, host factors encompass:

Biological & Genetic Factors: Family history of substance use disorder, metabolic rate, genetic polymorphisms affecting dopamine receptors or alcohol dehydrogenase enzymes.

Developmental Stage: Chronological age, neurodevelopmental maturity (such as the ratio of prefrontal cortex executive control to limbic emotional drive).

Psychological & Behavioral Attributes: Coping mechanisms, emotional regulation capacity, trauma history, sensation-seeking temperament, personal attitudes, perceived risk of harm, and values.

2. The Agent

The agent is the specific factor or vehicle whose presence, excessive presence, or relative absence is essential for the occurrence of the condition. In ATOD (Alcohol, Tobacco, and Other Drugs) prevention, the agent is the psychoactive substance itself:

Pharmacological Properties: Bioavailability, potency, chemical purity, receptor binding affinity (e.g., fentanyl vs. morphine), and half-life.

Addictive Liability: Speed of reinforcement, onset of tolerance, and severity of physical withdrawal.

Delivery Method & Formulation: Inhalation (vaping, smoking), intravenous injection, insufflation, or oral ingestion (edibles, pills). Higher speed of absorption to the brain correlates with higher addictive potential.

3. The Environment

The environment includes all external physical, social, economic, cultural, and political conditions that surround and influence the host and agent:

Physical Environment: Density of alcohol retailers, vape shops, or cannabis dispensaries within a neighborhood; presence of drug paraphernalia; availability of parks, lighting, and prosocial community centers.

Social & Cultural Environment: Normative beliefs regarding drinking and drug use, family stability, peer group behaviors, community trauma, historical marginalization, and media representations.

Economic & Policy Environment: Price elasticity of substances (excise tax rates), legal purchasing age laws, local zoning regulations, advertising restrictions, and enforcement of underage sales bans.

Note

Prevention In Action: Early historical drug education attempted to modify only the host through fear-based lectures. Modern evidence-based prevention recognizes that modifying the environment (e.g., passing smoke-free air ordinances, restricting retail alcohol outlet density, raising taxes) is frequently far more impactful at shifting population-level health outcomes than working with hosts in isolation.

Epidemiological Surveillance in Prevention

Prevention specialists rely on epidemiological data collection systems to monitor patterns, detect emerging drug trends, and evaluate community intervention outcomes. Three prominent national surveillance instruments are central to behavioral health:

National Survey on Drug Use and Health (NSDUH): Conducted annually by SAMHSA, surveying the civilian, non-institutionalized U.S. population aged 12 and older to provide national and state-level estimates of tobacco, alcohol, illicit drug use, and mental health indicators.

Youth Risk Behavior Surveillance System (YRBSS): Managed by the Centers for Disease Control and Prevention (CDC), monitoring health-risk behaviors (including ATOD use, violence, dietary habits, and sexual behaviors) among representative samples of high school students.

Monitoring the Future (MTF): Conducted by the University of Michigan's Institute for Social Research (funded by NIDA), tracking substance use trends, perceived availability, disapproval, and perceived risk of harm among 8th, 10th, and 12th-grade students nationwide.

Key epidemiological metrics include incidence (the rate of newly diagnosed cases or first-time substance use initiation within a specified population over a defined time period) and prevalence (the total proportion of individuals in a population exhibiting a condition or behavior at a specific point in time, such as 30-day past-use prevalence).

Basic Epidemiology Term Meaning Prevention Example

Incidence New cases or first uses in a population during a set period Number of 8th graders who first tried vaping this school year

Prevalence All existing cases or users at a point or during a period Lifetime, past-year, or past-30-day use rates

Rate A count divided by the population, often per 1,000 or 100,000 Overdose deaths per 100,000 residents

Morbidity / Mortality Illness or injury / deaths from a condition ED visits for alcohol poisoning / overdose deaths

Relative risk or odds ratio How much more likely an outcome is in one group than another Early-onset drinkers compared with later-onset drinkers

Trend The direction of change over time Daily cannabis use rising across three survey cycles

Disparity A difference in burden between groups or places Higher overdose rates in one neighborhood or population

The Institute of Medicine (IOM) Continuum of Care

In 1994, the Institute of Medicine (IOM)—now known as the National Academy of Medicine —published a landmark framework in its report Reducing Risks for Mental Disorders: Frontiers for Preventive Intervention Research . This model, widely adopted and expanded by the Substance Abuse and Mental Health Services Administration ( SAMHSA ), organized behavioral health interventions into a comprehensive continuum: +-----------------------------------------------------------------------------------------+

  • | THE BEHAVIORAL HEALTH CONTINUUM OF CARE |
  • +-------------------+-----------------------------------+-----------------+---------------+
  • | PROMOTION | PREVENTION | TREATMENT | MAINTENANCE |
  • +-------------------+-----------+-----------+-----------+--------+--------+-------+-------+
  • | Enhancing | Universal | Selective | Indicated | Case | Stand- | Adher-| Re- |
  • | Well-Being & | (General | (Elevated | (Early | Identi-| ard | ence | lapse |
  • | Resilience | Pop.) | Risk Sub- | Signs / | fica- | Care | with | Prev. |
  • | | | groups) | Precursor)| tion | | Care | / RSS |
  • +-------------------+-----------+-----------+-----------+--------+--------+-------+-------+
  • 1. Health Promotion

Interventions at the promotion stage aim to optimize overall psychological and physical well-being, foster resilience, strengthen protective factors, and establish environments that encourage positive human development. Health promotion interventions are non-stigmatizing and delivered across whole communities regardless of risk status (e.g., social-emotional learning integrated into early childhood preschools, community-wide parenting skills workshops, workplace wellness initiatives).

2. Prevention

The prevention segment of the continuum encompasses all interventions delivered prior to the onset of a diagnosable clinical disorder . It replaces ambiguous legacy terminology (such as primary vs. secondary) with three operational tiers based on the risk profile of the target audience:

A. Universal Prevention

Target Audience: The general public or a whole population group that has not been identified on the basis of individual risk. Every individual in the defined population receives the intervention, regardless of their individual vulnerability.

Screening Required: None. Universal interventions do not require assessment, screening, or risk profiling of individual participants.

Operational Focus: Broad-based delay of substance initiation, establishing healthy social norms, and modifying macro-environmental conditions.

Cost & Reach Dynamics: Low cost per participant, high overall community reach.

Programmatic Examples:

Comprehensive, evidence-based substance misuse curricula (e.g., LifeSkills Training ) delivered to all 6th, 7th, and 8th-grade students in a school district.

Enactment and enforcement of public health policies, such as the Minimum Legal Drinking Age (MLDA 21) or tobacco excise tax increases.

Multi-channel public awareness campaigns using social norming strategies to debunk perceptions that "every teen drinks."

Responsible Beverage Service (RBS) training mandated for all alcohol servers and retail clerks across a municipality.

B. Selective Prevention

Target Audience: Specific sub-populations or sub-groups whose risk of developing substance use disorders is significantly higher than the general population, based on biological, psychological, economic, or environmental risk factors, but who do not yet manifest early symptoms or diagnoses .

Screening Required: Group-level demographic, biological, or environmental risk identification (e.g., membership in an identified high-risk group), but not individual clinical screening for substance use symptoms.

Operational Focus: Mitigating known risk factors and amplifying protective factors for vulnerable groups before experimentation occurs.

Cost & Reach Dynamics: Moderate cost per participant, targeted reach.

Programmatic Examples:

Support groups and resilience-building programs for Children of Substance-Using Parents (COAs), who carry genetic and environmental vulnerabilities.

Targeted mentorship, life skills, and academic support for youth in foster care , those experiencing housing instability, or youth in juvenile justice diversion programs.

Structured after-school programs for adolescents living in neighborhoods characterized by extreme economic distress, community disorganization, and high violent crime rates.

Specialized transition workshops for military families experiencing parental deployment.

C. Indicated Prevention

Target Audience: High-risk individuals who have been identified as exhibiting early detectable signs, precursors, or subclinical experimental behaviors associated with substance misuse (e.g., early experimentation, binge drinking episodes, school truancy, emerging conduct problems), but who do not currently meet formal clinical diagnostic criteria for a Substance Use Disorder under the DSM-5.

Screening Required: Yes. Requires individual-level screening or behavioral assessment to identify early warning signs, behavioral infractions, or experimental consumption.

Operational Focus: Stopping progression, reversing early experimental use, preventing escalation into dependence, and addressing specific individual risk profiles.

Cost & Reach Dynamics: High cost per participant, narrow and highly intensive reach.

Programmatic Examples:

A student assistance intervention (such as Project Toward No Drug Abuse or Teen Intervene ) for students caught vaping cannabis or drinking on school grounds.

Screening, Brief Intervention, and Referral to Treatment (SBIRT) administered by adolescent health clinics when a routine screen reveals occasional binge drinking.

Small-group cognitive-behavioral skills interventions for youth exhibiting early anti-social behaviors and academic failure combined with self-reported alcohol experimentation.

3. Treatment

When an individual's substance use progresses to the point of meeting formal diagnostic criteria for a mild, moderate, or severe Substance Use Disorder, prevention gives way to clinical treatment:

Case Identification: Standardized diagnostic assessment by licensed clinicians to identify diagnosis, severity, and psychiatric comorbidities.

Standard Treatment: Medically managed withdrawal (detoxification), outpatient therapy, Intensive Outpatient Programs (IOP), residential/inpatient rehabilitation, and Medication-Assisted Treatment / Medications for Opioid Use Disorder (MAT/MOUD; e.g., buprenorphine, methadone, extended-release naltrexone).

4. Maintenance

Interventions supporting long-term stabilization and community reintegration following acute treatment:

Adherence: Ongoing monitoring and medical management to sustain pharmacological and psychological treatment compliance.

Relapse Prevention & Recovery Support Services (RSS): Peer recovery coaching, collegiate recovery programs, recovery community centers, sober living environments, and 12-step mutual aid fellowships (e.g., AA, NA, SMART Recovery).

Comparison of the Three IOM Prevention Tiers

Telling Universal, Selective, and Indicated prevention apart is a core PS skill; sample question 8 in the IC&RC Candidate Guide asks candidates to classify a youth program by tier:

Feature Universal Prevention Selective Prevention Indicated Prevention

Target Selection Whole population (e.g., all 8th graders) High-risk group (e.g., children of parents with SUD) High-risk individual with early signs (e.g., teen caught binge drinking)

Individual Screening No screening conducted Group characteristics identified, no individual symptom screen Individual screening/assessment required to detect warning signs

Current Substance Use Assumed non-users; baseline unknown Assumed non-users or general baseline; group risk Showing early experimental use or precursor problem behaviors

Diagnostic Status No diagnosis No diagnosis Subclinical; does NOT meet SUD diagnostic criteria

Primary Mechanism Universal skills, environmental policy, media campaigns Targeted psychoeducation, resilience building, protective buffers Brief motivational interviewing, intensive behavioral modification

Stigma Potential Extremely low (everyone participates) Low to moderate (requires careful framing to avoid labeling) Moderate to high (targeted at individuals with infractions/signs) +-------------------------------------------+

  • | IOM Prevention Tiers |
  • +-------------------------------------------+
  • | 1. Universal: General Population |
  • | (No screening, broad reach) |
  • +-------------------------------------------+
  • | 2. Selective: Elevated Subgroup Risk |
  • | (No symptom screen, demographic risk) |
  • +-------------------------------------------+
  • | 3. Indicated: Individual Early Signs |
  • | (Symptom screen, subclinical use) |
  • +-------------------------------------------+

Loading diagram... The IOM Continuum of Care Framework